{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:55:33Z","timestamp":1791096933781,"version":"4.1.0"},"reference-count":100,"publisher":"The Royal Society","issue":"suppl_1","license":[{"start":{"date-parts":[[2009,11,25]],"date-time":"2009-11-25T00:00:00Z","timestamp":1259107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/royalsociety.org\/journals\/ethics-policies\/data-sharing-mining\/"}],"content-domain":{"domain":["royalsocietypublishing.org"],"crossmark-restriction":true},"short-container-title":["J. R. Soc. Interface."],"published-print":{"date-parts":[[2010,2,6]]},"abstract":"<jats:p>Limitations in therapy induced by adverse effects due to unselective drug availability and therefore the use of potentially too high doses are a common problem. One prominent example for this dilemma are inflammatory diseases. Colloidal carriers allow one to improve delivery of drugs to the site of action and appear promising to overcome this general therapeutic drawback. Specific uptake of nanoparticles by immune-related cells in inflamed barriers offers selective drug targeting to the inflamed tissue. Here we focus on nanocarrier-based drug delivery strategies for the treatment of common inflammatory disorders like rheumatoid arthritis, multiple sclerosis, uveitis or inflammatory bowel disease.<\/jats:p>","DOI":"10.1098\/rsif.2009.0285.focus","type":"journal-article","created":{"date-parts":[[2009,11,26]],"date-time":"2009-11-26T04:40:00Z","timestamp":1259210400000},"update-policy":"https:\/\/doi.org\/10.1098\/crossmark-policy","source":"Crossref","is-referenced-by-count":132,"title":["Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases"],"prefix":"10.1098","volume":"7","author":[{"given":"Wiebke","family":"Ulbrich","sequence":"first","affiliation":[{"name":"Laboratory of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alf","family":"Lamprecht","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmaceutical Technology and Biopharmaceutics, University of Bonn, Bonn, Germany"},{"name":"Laboratory of Pharmaceutical Engineering, University of Franche-Comt\u00e9, Besan\u00e7on, France"},{"name":"Institut Universitaire de France, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"175","published-online":{"date-parts":[[2009,11,25]]},"reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2006.06.029"},{"key":"e_1_3_1_3_1","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0022-3565(24)36473-0","article-title":"Effects of cyclosporine or FK506 in chronic colitis","volume":"280","author":"Aiko S.","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.29.11.1531"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1211\/0022357022476"},{"key":"e_1_3_1_6_1","article-title":"Nanomedicines for ocular NSAIDs: safety on drug delivery","author":"Ara\u00fajo J.","journal-title":"Nanomedicine"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-001-1266-6"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc800257m"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425240903167926"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200009)43:9<1951::AID-ANR5>3.0.CO;2-K"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600840420"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.6.369"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(02)00044-3"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2006.03.028"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.wco.0000169736.60922.20"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.11.6164"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1159\/000065608"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000119866"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1995.tb05544.x"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/35025220"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp8001478"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M900280200"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2005.05.044"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199904000-00015"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1191\/1352458504ms1090oa"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2006.11.028"},{"key":"e_1_3_1_27_1","first-page":"223","article-title":"Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis","volume":"20","author":"Dousset V.","year":"1999","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"e_1_3_1_28_1","first-page":"1000","article-title":"MR imaging of relapsing multiple sclerosis patients using ultra-small-particle iron oxide and compared with gadolinium","volume":"27","author":"Dousset V.","year":"2006","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022298725165"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.539_g.x"},{"key":"e_1_3_1_31_1","article-title":"Corticosteroids or ACTH for acute exacerbations in multiple sclerosis","volume":"4","author":"Filippini G.","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.3109\/08860229909085094"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(99)00447-0"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2007.12.021"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410290515"},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-009-9834-1"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2007.10.004"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2006.08.049"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00385.x"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004151"},{"key":"e_1_3_1_41_1","first-page":"359","article-title":"\u03b1-Methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy","volume":"3","author":"Hwang J.","year":"2008","journal-title":"Int. J. Nanomed."},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1023\/B:PHAM.0000019298.29561.cd"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/mp0499095"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1080\/10611860600648429"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1081\/DDC-120003445"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2008.10.013"},{"key":"e_1_3_1_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/10623320213631"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21719"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(01)00219-8"},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.06-1305"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011032328064"},{"key":"e_1_3_1_52_1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0022-3565(24)29290-9","article-title":"Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease","volume":"299","author":"Lamprecht A.","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_1_53_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.088146"},{"key":"e_1_3_1_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2008.02.005"},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.48.2.143"},{"key":"e_1_3_1_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.09.015"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s005350070065"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2006.01.032"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.11140"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1679\/aohc.71.195"},{"key":"e_1_3_1_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-409X(95)00043-7"},{"key":"e_1_3_1_63_1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi S. M.","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"e_1_3_1_64_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-2747rev"},{"key":"e_1_3_1_65_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015888212948"},{"key":"e_1_3_1_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2008.08.009"},{"key":"e_1_3_1_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2008.12.018"},{"issue":"2","key":"e_1_3_1_68_1","first-page":"117","article-title":"Mechanisms of action of sucralfate","volume":"3","author":"Nagashima R.","year":"1981","journal-title":"J. Clin. Gastroenterol."},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00832000"},{"key":"e_1_3_1_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2007.08.008"},{"key":"e_1_3_1_71_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018985308984"},{"key":"e_1_3_1_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/40.9.978"},{"key":"e_1_3_1_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2005.09.003"},{"key":"e_1_3_1_74_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2631433100"},{"key":"e_1_3_1_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-005-0091-7"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg176"},{"key":"e_1_3_1_77_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.30.4.486"},{"key":"e_1_3_1_78_1","first-page":"217","article-title":"Chronic inflammation and cancer","volume":"16","author":"Shacter E.","year":"2002","journal-title":"Oncology (Williston Park)"},{"key":"e_1_3_1_79_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-008-0676-7"},{"key":"e_1_3_1_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(00)00339-4"},{"key":"e_1_3_1_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2004.01.007"},{"key":"e_1_3_1_82_1","doi-asserted-by":"publisher","DOI":"10.1385\/IR:22:2-3:299"},{"key":"e_1_3_1_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.11.012"},{"key":"e_1_3_1_84_1","first-page":"G203","article-title":"Disruption of intestinal barrier function associated with experimental colitis: possible role of mast cells","volume":"274","author":"Stein J.","year":"1998","journal-title":"Am. J. Physiol."},{"key":"e_1_3_1_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/0169-409X(95)00039-A"},{"key":"e_1_3_1_86_1","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6673-2-16"},{"key":"e_1_3_1_87_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2515"},{"key":"e_1_3_1_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00149-1"},{"key":"e_1_3_1_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2003.10.004"},{"key":"e_1_3_1_90_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.5.7.767"},{"key":"e_1_3_1_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0171-2985(96)80026-X"},{"key":"e_1_3_1_92_1","doi-asserted-by":"publisher","DOI":"10.3109\/03009749509100906"},{"key":"e_1_3_1_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0939-6411(97)00114-8"},{"key":"e_1_3_1_94_1","article-title":"The potential of liposomal drug delivery for the treatment of inflammatory arthritis","author":"Vanniasinghe A. S.","journal-title":"Semin. Arthritis Rheum."},{"key":"e_1_3_1_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20685"},{"key":"e_1_3_1_96_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn009"},{"key":"e_1_3_1_97_1","unstructured":"von Briesen H et al. 2006 Fraunhofer Institut f\u00fcr Biomedizinische Technik from Pharmazeutische Zeitung 04\/2009."},{"key":"e_1_3_1_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2007.10.014"},{"key":"e_1_3_1_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(04)00937-8"},{"key":"e_1_3_1_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5173(01)00854-7"},{"key":"e_1_3_1_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.1158"}],"container-title":["Journal of The Royal Society Interface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsif.2009.0285.focus","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/royalsocietypublishing.org\/doi\/full-xml\/10.1098\/rsif.2009.0285.focus","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsif.2009.0285.focus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T12:25:01Z","timestamp":1739449501000},"score":1,"resource":{"primary":{"URL":"https:\/\/royalsocietypublishing.org\/doi\/10.1098\/rsif.2009.0285.focus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,25]]},"references-count":100,"journal-issue":{"issue":"suppl_1","published-print":{"date-parts":[[2010,2,6]]}},"alternative-id":["10.1098\/rsif.2009.0285.focus"],"URL":"https:\/\/doi.org\/10.1098\/rsif.2009.0285.focus","relation":{},"ISSN":["1742-5689","1742-5662"],"issn-type":[{"value":"1742-5689","type":"print"},{"value":"1742-5662","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,25]]},"assertion":[{"value":"2009-07-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-11-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-11-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}